{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:26:34Z","timestamp":1757705194673},"reference-count":13,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Canada Research Chair in Childhood Arthritis"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.jclinepi.2009.11.019","type":"journal-article","created":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T05:00:33Z","timestamp":1272690033000},"page":"1363-1369","source":"Crossref","is-referenced-by-count":5,"title":["Response times follow lognormal or gamma distribution in arthritis patients"],"prefix":"10.1016","volume":"63","author":[{"given":"Lusine","family":"Abrahamyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Beyene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JingYuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Chon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Willan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrike","family":"Schmeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Horneff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward C.","family":"Keystone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian M.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2009.11.019_bib1","series-title":"Statistical methods for survival data analysis","author":"Lee","year":"2003"},{"issue":"2","key":"10.1016\/j.jclinepi.2009.11.019_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0197-2456(90)90005-M","article-title":"Power and sample size calculations. A\u00a0review and computer program","volume":"11","author":"Dupont","year":"1990","journal-title":"Control Clin Trials"},{"issue":"3","key":"10.1016\/j.jclinepi.2009.11.019_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2307\/2531201","article-title":"Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification","volume":"42","author":"Lachin","year":"1986","journal-title":"Biometrics"},{"key":"10.1016\/j.jclinepi.2009.11.019_bib4","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/0091270005277938","article-title":"Rheumatoid arthritis: an overview of new and emerging therapies","volume":"45","author":"Doan","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jclinepi.2009.11.019_bib5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","article-title":"Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial","volume":"363","author":"Klareskog","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2009.11.019_bib6","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard.2003.014886","article-title":"The German etanercept registry for treatment of juvenile idiopathic arthritis","volume":"63","author":"Horneff","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.jclinepi.2009.11.019_bib7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/ard.2007.087593","article-title":"Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry","volume":"68","author":"Horneff","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jclinepi.2009.11.019_bib8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780360601","article-title":"The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials","volume":"36","author":"Felson","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jclinepi.2009.11.019_bib9","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","article-title":"Preliminary definition of improvement in juvenile arthritis","volume":"40","author":"Giannini","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jclinepi.2009.11.019_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1097-0258(19980130)17:2<219::AID-SIM735>3.0.CO;2-O","article-title":"Tutorial in biostatistics methods for interval-censored data","volume":"17","author":"Lindsey","year":"1998","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.jclinepi.2009.11.019_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/0049124104268644","article-title":"Multimodel inference. Understanding AIC and BIC in model selection","volume":"33","author":"Burnham","year":"2004","journal-title":"Sociol Methods Res"},{"key":"10.1016\/j.jclinepi.2009.11.019_bib12","series-title":"Model selection and multimodel inference: a practical information-theoretic approach","author":"Burnham","year":"2002"},{"key":"10.1016\/j.jclinepi.2009.11.019_bib13","author":"U.S. Food and Drug Administration"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435610000661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435610000661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T07:24:19Z","timestamp":1544513059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435610000661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0895435610000661"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2009.11.019","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}